Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Latin America Health Times.
Press releases published on April 7, 2025
35th Annual National Suicide Prevention Conference in Richmond Hill, Ontario
GlobeNewswire
·
April 7, 2025
RICHMOND HILL, Ontario, April 07, 2025 (GLOBE NEWSWIRE) -- The Canadian Association for Suicide Prevention (CASP) is thrilled to announce the 35th Annual National Suicide Prevention Conference, scheduled to take place May 14 - 16, 2025, at the Sheraton …
Tanke Biosciences Corp Announces the Appointment of John P. Hopkins Executive Chairman of the Board of Directors
GlobeNewswire
·
April 7, 2025
Las Vegas, Nevada, April 07, 2025 (GLOBE NEWSWIRE) -- Tanke Biosciences Corp (the “Company”) (OTC: TNBI) announced today that John P. Hopkins has been appointed Executive Chairman of the Company’s Board of Directors, effective March 31st, 2025. Mr. Hopkins …
Burble Creativity to Sponsor Autism Health Summit in San Diego, California
EIN Presswire
·
April 7, 2025
Hundreds of parents and experts are coming to San Diego April 11-13 to learn about the most recent developments in autism research, therapies, and more. MURRIETA, CA, UNITED STATES, April 7, 2025 /EINPresswire.com/ -- Burble Creativity, Inc., an …
Bluejay Diagnostics Announces Entry into Warrant Inducement Transaction for Approximately $3.7 Million in Gross Proceeds
GlobeNewswire
·
April 7, 2025
ACTON, Mass., April 07, 2025 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical technology company developing rapid diagnostics on its Symphony platform to improve patient outcomes in critical care settings …
Merit Medical Systems to Announce First Quarter 2025 Results on April 24, 2025
GlobeNewswire
·
April 7, 2025
SOUTH JORDAN, Utah, April 07, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will release its financial results for the quarter ended March …
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 7, 2025
BEDFORD, Mass., April 07, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global leader in the Osteoarthritis (“OA”) Pain Management and Regenerative Solutions space focused on early intervention orthopedics, today announced that on …
PainReform Provides Year-End Business Update
GlobeNewswire
·
April 7, 2025
TEL AVIV, Israel, April 07, 2025 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a specialty pharmaceutical company focused on the reformulation of established therapeutics and commercialization of the DeepSolar …
AleYoga lanza una iniciativa para concienciar sobre los beneficios del yoga para los hombres
EIN Presswire
·
April 7, 2025
El yoga, con miles de años de historia, se ha convertido en una disciplina integral que combina fuerza, flexibilidad y equilibrio mental ALICANTE, ANDALUSIA, SPAIN, April 7, 2025 /EINPresswire.com/ -- Hemos planteado estas preguntas a Alejandra, …
Avicanna Announces Receipt of Management Cease Trade Order and Provides Bi-Weekly Status Update
GlobeNewswire
·
April 7, 2025
Auditor Licensing …
Jeune Aesthetics Appoints Marc Forth as Chief Executive Officer
GlobeNewswire
·
April 7, 2025
PITTSBURGH, April 07, 2025 (GLOBE NEWSWIRE) -- Jeune Aesthetics, Inc. (“Jeune”), a wholly owned subsidiary of Krystal Biotech, Inc. (“Krystal”) (NASDAQ: KRYS) leveraging Krystal’s clinically validated gene-delivery platform to fundamentally address and …
Oragenics, Inc. Participates in the 3rd Nasal Formulation & Delivery Summit
GlobeNewswire
·
April 7, 2025
SARASOTA, Fla., April 07, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biotechnology company focused on developing novel intranasal therapies for brain-related disorders, today announced that Chief Medical Officer Dr. James Kelly …
Pacira BioSciences Announces Settlement of U.S. Patent Litigation for EXPAREL
GlobeNewswire
·
April 7, 2025
-- Fresenius Kabi licensed to sell volume-limited amounts of generic bupivacaine liposome injectable suspension in the U.S. no earlier than a confidential date in 2030 -- -- Fresenius also licensed to sell generic bupivacaine liposome injectable suspension …
CareMed Has Been Selected as a National Specialty Pharmacy Partner for VANRAFIA™ (atrasentan)
GlobeNewswire
·
April 7, 2025
NEW HYDE PARK, N.Y., April 07, 2025 (GLOBE NEWSWIRE) -- CareMed, an independent specialty pharmacy, is in the Limited Distribution Network for Vanrafia™ (atrasentan), for the reduction of proteinuria in adults with primary immunoglobulin A nephropathy ( …
Solésence Announces Uplisting to Nasdaq
GlobeNewswire
·
April 7, 2025
Trading set to begin Tuesday, April 8 under new ticker “SLSN” ROMEOVILLE, Ill., April 07, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (OTCQB: NANX), a leader in scientifically-driven health care solutions across beauty and life science categories, today …
Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2025 Financial Results on May 8, 2025
GlobeNewswire
·
April 7, 2025
CANTON, Mass., April 07, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and …
Pliant Therapeutics Announces Upcoming Presentations at the 2025 American Thoracic Society International Conference
GlobeNewswire
·
April 7, 2025
SOUTH SAN FRANCISCO, Calif., April 07, 2025 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX) today announced that the Company will present three scientific posters at the upcoming 2025 American Thoracic Society (ATS) International Conference, …
CVRx Reports Preliminary First Quarter 2025 Financial Results
GlobeNewswire
·
April 7, 2025
MINNEAPOLIS, April 07, 2025 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company, today announced certain preliminary unaudited first quarter 2025 revenue results. “While we continue to make significant progress …
Clover Health Appoints Industry Veteran as Chief Medical Officer of Medicare Advantage
GlobeNewswire
·
April 7, 2025
WILMINGTON, Del., April 07, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced the appointment of Dr. Shelly Gupta as Chief Medical Officer (“CMO”). Dr. Gupta will oversee …
Tevogen Bio Highlights Most Recent Insider Ownership of 74%; Management Maintains Conviction in the Company’s Mission
GlobeNewswire
·
April 7, 2025
WARREN, N.J., April 07, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), a healthcare company with dedicated efforts in immunotherapy and artificial intelligence, is unified by a commitment to advancing patient- …
LeMaitre Will Announce First Quarter 2025 Earnings Results May 1, 2025
GlobeNewswire
·
April 7, 2025
BURLINGTON, Mass., April 07, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its first quarter 2025 financial results on Thursday, May 1, 2025, after the market close. The company has scheduled a …